Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers.

Brandon M Huffman,Vasily N Aushev,Griffin L Budde,Joseph Chao,Farshid Dayyani,Diana Hanna,Gregory P Botta,Daniel V T Catenacci,Steven B Maron,Shifra Krinshpun,Shruti Sharma,Giby V George,Meenakshi Malhotra,Adham Jurdi,Solomon Moshkevich,Alexey Aleshin,Pashtoon M Kasi,Samuel J Klempner

JCO precision oncology（2022）

Cited 14|Views33

No score

Abstract

Using real-world data, we demonstrate that postoperative tumor-informed ctDNA detection in EGC is feasible and allows for enhanced patient risk stratification and prognostication during curative-intent therapy.

Translated text

Key words

circulating tumor dna,esophageal

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined